SCHEMBL8291709

SCHEMBL8291709

C=CCNC(=O)C(=O)[C@@H]1CCCCCCCOC[C@H](NC(=O)N[C@H](CN2CCC(C)(C)CC2=O)C(C)(C)C)C(=O)N2C[C@@H]3C[C@@H]3[C@H]2C(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8291707 0.92 CPB2 (0.30) —
SCHEMBL8291708 0.91 PSMB9 (0.32) —
SCHEMBL8290534 0.91 — —
SCHEMBL12607978 0.84 PPIA (0.30) —
SCHEMBL7860503 0.84 — —
SCHEMBL8045437 0.83 PSMB9 (0.34) —
SCHEMBL8291706 0.83 CPB2 (0.30) —
SCHEMBL13685112 0.83 CPB2 (0.30) —
SCHEMBL12607905 0.83 CPB2 (0.30) —
SCHEMBL12606772 0.80 CPB2 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005030796-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-04-07 — — WO disclosed
Send feedback